Mowad-Nassar is Senior Vice President at AbbVie and President, Specialty and U.S. Therapeutics Operations Her appointment brings over 30 years of strategic, commercial, and operational expertise in the pharmaceutical and broader healthcare industry, with a focus on digital innovation SAN DIEGO, Aug. 18, 2025 (Korea Bizwire) – Resmed (NYSE: RMD, ASX: RMD) today announced the [...]
Acquisition supports Resmed’s growth in virtual care, expands access to diagnosis, and enhances the digital experience for patients and providers SAN DIEGO, May 01, 2025 (Korea Bizwire) — Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, today announced it has acquired VirtuOx, a [...]
Former Illumina, MSCI, and Moody’s executive brings extensive experience leading engagement with the global investment community SAN DIEGO, April 21, 2025 (Korea Bizwire) – Resmed (NYSE: RMD, ASX: RMD), the global leader in health technology focused on sleep, breathing, and care delivered in the home, today announced the appointment of Salli Schwartz as Chief Investor Relations Officer, effective [...]
New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships 7 out of 10 employed respondents have called in sick at least once in their career due to poor sleep. 18% of couples reported sleeping in separate rooms due to snoring and [...]
ResMed studies presented at SLEEP 2024 also revealed a 17% prevalence of insomnia among adults in North America, Latin America, and the Caribbean, and a higher rate of depression in women with OSA SAN DIEGO, June 10, 2024 (Korea Bizwire) – In collaboration with leading medical researchers from around the world, ResMed (NYSE: RMD, ASX: [...]
Justin Leong appointed Chief Product Officer, effective immediately. Katrin Pucknat appointed Chief Marketing Officer, effective immediately. Mike Fliss appointed Chief Revenue Officer, effective immediately. Rob Douglas, President and Chief Operating Officer, to retire January 1, 2024. SAN DIEGO, Nov. 09 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced a new operating model to [...]
SAN DIEGO, July 5 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced the acquisition of privately held Somnoware, a U.S. leader in sleep and respiratory care diagnostics software. Somnoware software streamlines the processes of physicians as well as sleep and pulmonary function testing labs for diagnosing and evaluating a patient’s sleep and respiratory [...]
INDIANAPOLIS, June 8 (Korea Bizwire) — People with heart failure and obstructive sleep apnea (OSA) can significantly reduce hospitalizations and ER visits as well as related costs by being adherent on positive airway pressure (PAP) therapy, according to two studies supported by ResMed (NYSE: RMD, ASX: RMD) and presented at SLEEP 2023. Key Results One [...]
France’s Jean-Louis Pépin and Germany’s Holger Woehrle presented studies in which treating OSA with CPAP lowered all-cause mortality for PAP vs. non-PAP users with OSA Germany’s Michael Arzt presented new evidence that treating CSA with ASV* caused “a significant and clinically relevant improvement in disease-specific QoL, daytime sleepiness, and quality of sleep” WASHINGTON, May 25 (Korea [...]
SAN DIEGO, May 2 (Korea Bizwire) — ResMed (NYSE: RMD, ASX: RMD) today announced the appointment of two new executive team members: Michael Rider, Global General Counsel & Secretary, effective July 1, 2023, and Dawn Haake as ResMed’s first Chief Quality Officer, effective May 1, 2023. Both joined ResMed’s executive team on May 1 and [...]